Principles of Dialysis
Indications & Contraindications
Hemodialysis
Hemodialysis related therapies
Peritoneal Dialysis
Other
Minitips

Publications

☼ Published papers 

* Abstract presented in international conferences

●Abstract presented in Arab Conferences 

♣ Poster presentation

җ Thesis

 

1-G.Cusma, N.AlHilali, G.M.Abouna: Renal replacement therapy in Kuwait. In Current Status of Organ Transpplantation.1984, 197-191.

 

2 G.Cusma, M.C.Cusma,J.V.Meulin,N. Al Hilali. S. Aburomeh, K.V.Johny:

Predominant gram negative bacterial peritonitis in CAPD in Kuwait.     Presented at IV Congress of the international society of peritoneal dialysis Venice July 1987.Perit. dial. Bull.: 7 ,2 , 19 ,1987*

 

3-N. Al Hilali G.Cusma, S. Aburomeh,J.V.Meulen,K.V.Johny:Incidence of peritonitis   ,distribution of causative bacteria and outcome in continuous ambulatory peritoneal dialysis(CAPD) in Kuwait. Acta Pathologica Microbiologica Et Immunologica Scandinavia [APMIS]Vol.96 s3,101-103,1988.

 

4.N.Al Hilali :Peritonitis in continuous Ambulatory Peritoneal Dialysis and Intermittent Peritoneal Dialysis. Thesis submitted in partial fulfillment of Master Degree in Medicine,1988.Faculty of Medicine, Ain Shams University. җ

 

5-J.V.Meulen ,N.Al Hilali, K.V.Johny:Renal concentration defect in Kuwaiti patient with sickle cell disease.Annals of Tropical Medicine and Pathology.1988;Vol 82; No2;207-208.

 

6-N.Al-Hilali,N.Nampoory.R.K.Gupta,K.V.Johny:Continuous Ambulatory Peritoneal Dialysis and Intermittent Peritoneal Dialysis.A comparative study on its complications and viability.(Abstract) Presented  at Dialysis Symposium ,King saud University. College of Medicine. January 1989 .Riyadh,Saudia Arabia .

 

7 N.Al-Hilali , N.Nampoory. R.K.Gupta,K.V.Johny, Continuous Ambulatory Peritoneal Dialysis and Intermittent Peritoneal Dialysis. A comparative study on its complications and viability. Abstract) Presented  at XITH Intrnational Congress of Nephrology July 15 - 20 ,1990.Tokyo ,Japan. *

 

8-R.K.Gupta,N.AlHilali,NAlTamimi.N.Nampoory,K.V.Johny:A Comparative prospective study of single pass system to recirculation dialysate     regenerative      system. Abstract) Presented  at Dialysis Symposium ,King Saud University. College of Medicine. January 1989 .Riyadh,Saudia Arabia.

 

9-N.Nampoory,N.Al Hilali,R.K.Gupta,G .Cusma, K.V.Johny :Clinical course of Diabetic Patient on Dialysis therapy. Abstract) Presented at 8th Congress of Kuwait Medical Association .November 1989.

 

10-N.Nampoory, N.Al Hilali ,J.Nassim ,N.Al Tamimi ,R.K.Gupta,K.V.Johny : Outcome of dialysis in end stage renal disease in Diabetes Miellitus.(Abstract)Presented at 4th International Medical Science Conference. March 1990. *

 

11-N.Al-Hilali ,N.Nampoory .R.K.Gupta, K.V.Johny : Clinical course and outcome of dialysis in end stage Lupus Nephritis. Presented at the Second Congress of the Arab Society and Renal Transplantation .Cairo November 1991.

 

12-K El Reshaid ,K V Johny ,M Georgous ,N Nampoory ,N Al Hilali .Impact of Iraqi Occupation of Kuwait ESRD patient 1990-1991.Neph. Dial & Transplant 1993 ;8:7-10.

 

13-N Al-Tamimi , RK Gupta , N Al Hilali , J N Costandi , N Nampoory , A Al Shayeb , KV Johny. Acute  Interstitial Nephritis due to Chloramphenicol  Medical Principles and Practice 1994-95 ;4:54-56.

 

14- K El Reshaid ,M Kapoor , T Sugathan ,S Al Mofti , N Al Hilali . Hepatitis C virus Infection in Patients on Maintenance Dialysis in Kuwait :Epidemiological Profile and Efficacy of Prophylaxis. Saudi J Kidney Dis Transplant1995;6: 144-150.

 

15-N Nampoory , N AL Hilali ,M Seshadri ,A Abdulla A Kanagasabhapathy , N.C. Nayak , K.V. Johny. Aluminum Monitoring for Chronic Renal Failure in Kuwait. Saudi J Kidey Dis Transplant 1996;7(1):27-30

 

16-N Nampoory , K.V. Johny, N AL Hilali ,M Seshadri , A Kanagasabhapathy ,. Erythropoietin Deficiency and Relative Resistance cause Anaemia in Post-renal Transplant Recipients with Normal Renal function. Nephrol Dial Transplant. (1996) 11 : 177-181 and (Poster) presented at the 1st h annual health sciences poster day April 22 -24 2002-♣ awarded as the best poster in clinical sciences.

 

17- N. Al Hilali. Continuous Arteriovenous Hemofiltration[CAVH]. Al Ataa-KNA , Proceeding of 13th Nurses's day in Kuwait and inernational Nurses' day 1997 May;(13):18-21.

 

18-N AL Hilali , N Nampoory , K.V. Johny TD Chugh. Bacillus cereus peritonitis in a chronic peritoneal dialysis patient. Perit Dial Int 1997 Sept;17(5):514-515

 

19-N. Nampoory,  K.V. Johny, C. Sarkar, I. Al-Masry, N. Al-Hilali and J.T. Anim. The dialysed patient with both Castlman disease and Kaposi sarcoma. Nephrol Dial Transplant. (1998) 13 : 2373-2376.

 

20- AL Hilali N.. Continuous Ambulatory Peritoneal Dialysis (CAPD)  Al Ataa-KNA , Proceedings of Inernational Nurses' day.1999 May, (15) 31-38

 

Al-Hilali N, Nampoory MR, Johny KV, Chugh TD.

Xanthomonas maltophilia infection in chronic peritoneal dialysis patients.
Scand J Urol Nephrol. 2000 Feb;34(1):67-9.
Department of Medicine and Microbiology, Mubarak Al-Kabeer Hospital, Kuwait.

 

22-N AL Hilali , N Nampoory , K.V. Johny .Neisseria cinerea peritonitis in a patient maintained on CAPD .Nephron

 

23-N AL Hilali , N Nampoory , K.V. Johny. Tuberculosis in dialysis patients in Kuwait. A single centre experience. Poster; presented on the 6th congress of the Arab society of nephrology and renal transplantation

 

24-N AL Hilali , N Nampoory , K.V. Johny , I Al-Misry. Tuberculosis in dialysis patients in Kuwait. A single centre experience. Kidney forum (2000)2,3, 26-28

 

25-N AL Hilali, V.T .Ninan, N Nampoory, FMY Hussain, J.H.Ali, M Samhan, K.V. Johny.  Superior Vena Cava Syndrome in Hemodialysis Patients. Abstract  Poster presentation  in the 7th congress of the Arab Society of Nephrology and Renal Transplantation. April 2-5   2002  Published in Saudi Journal of Kidney Diseases and Transplantation  June, 2003;14 (2): 186-189

 

26-V.T .Ninan, N AL Hilali, , J.H.Ali, N Nampoory K.V. Johny. Aetiology of end stage renal disease and outcome in Kuwait nationals on maintenance dialysis in a single center. Abstract; Poster presentation  in the 7th congress of the Arab Society of Nephrology and Renal Transplantation. April 2-5   2002 and Poster presented at the  8th annual health sciences Poster Say , April 21-23 2003♣

 

27-N AL Hilali, V.T .Ninan, N Nampoory J.H.Ali K.V. Johny.  Viability of home peritoneal dialysis in Arab Culture Abstract; Oral  presentation  in the 7th congress of the Arab Society of Nephrology and Renal Transplantation. April 2-5   2002and Poster presented at the 7th annual health sciences poster day April 22 -24 2002-

 

28-N AL Hilali, V.T. Ninan, N Nampoory J.H.Ali K.V. Johny.  Blood pressure control in hemodialysis patients: An audit. Poster presented at the 7th annual health sciences poster day April 22 -24 2002-

 

29- J.H.Ali, V.T .Ninan, N AL Hilali,  N Nampoory K.V. Johny. Outcome in eldery patients on maintenance dialysis. Poster presented at the 7th annual health sciences poster day April 22 -24 2002-

 

30-JN Costandy. N Al Hilali, M Miikael, MRN Nampoory, E Francis, K.V. Johny. Unusual presentation of lupus nephritis. Poster presented at the 7th annual health sciences poster day April 22 -24 2002-

 

31-N AL Hilali, V.T .Ninan, N Nampoory J.H.Ali, A Gawich K.V. Johny. Viability of home peritoneal dialysis: Experience with 100 patients from an Arab population. Abstract, Poster presentation in the First Asian Chapter Meeting – ISPD December 13-15  2002 Hong Kong. Peritoneal Dialysis International , 2002,Vol 22, Supplement 2, S42*

 

32-N AL Hilali, V.T .Ninan, J.H.Ali, Puliyclil MA. Profiled Hemodialysis. (Poster) presented at the  8th annual health sciences Poster Say , April 21-23 2003♣and

 

33-N AL Hilali, V.T .Ninan, J.H.Ali, Donia F, Rotimi VO. Mupirocin once weekly reduces the incidence of catheter exit site infection and alters the pattern of causative bacteria in peritoneal dialysis patients. (Poster) presented at the  8th annual health sciences Poster Say , April 21-23 2003♣ and

34-N AL Hilali, V.T .Ninan, N Nampoory, K.V. Johny J.H.A Homoud, F. Donia, JH. Ali. Two decades of peritoneal dialysis. Presented at the  9th annual health sciences Poster Say , April 21-23 2004 ♣ and

 

Nampoory MR, Das KC, Johny KV, Al-Hilali N, Abraham M, Easow S, Saed T, Al-Muzeirei IA, Sugathan TN, Al Mousawi M.

Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation.
Am J Kidney Dis. 2003 Oct;42(4):797-805.
Department of Medicine, Faculty of Medicine Kuwait University, Hamad Al Essa Organ Transplant Center, and Mubarak Al-Kabeer Hospital, Ministry of Health, Kuwait.

 

Al-Hilali N, Al-Humoud HM, Ninan VT, Nampoory MR, Ali JH, Johny KV.

Profiled hemodialysis reduces intradialytic symptoms.

Transplant Proc. 2004 Jul-Aug;36(6):1827-8.
Department of Medicine, Mubarak Al-kabeer Hospital, Kuwait.

Presented at the  9th annual health sciences Poster Say , April 21-23 2004 ♣ and

35-N AL Hilali,Vascular calcifications in dialysis patients presented at the  9th annual health sciences Poster Say , April 21-23 2004 ♣ and

 

35-N AL Hilali, V.T .Ninan, N Nampoory, K.V. Johny J.H.A Homoud, F. Donia, JH. Ali. Outcome and survival in different peritoneal dialysis modalities. Presented at XLI Congress of ERA. And EDTA. Nay 15-18, 2004. –Lisbon, Portugal. ♣ and*

Abstracts

 
 
Hypercoagulability, a serious problem in patients with ESRD on maintenance hemodialysis, and its correction after kidney transplantation.
Nampoory MR, Das KC, Johny KV, Al-Hilali N, Abraham M, Easow S, Saed T, Al-Muzeirei IA, Sugathan TN, Al Mousawi M
.
Am J Kidney Dis. 2003 Oct;42(4):797-805.
Department of Medicine, Faculty of Medicine Kuwait University, Hamad Al Essa Organ Transplant Center, and Mubarak Al-Kabeer Hospital, Ministry of Health, Kuwait.

BACKGROUND: Recurrent vascular access thrombosis (VAT) resulting in failure to continue maintenance hemodialysis (HD) therapy is not an uncommon event. The cause of VAT in these circumstances remains uncertain. We describe results of our studies to identify changes in hemostatic balance in patients on maintenance HD therapy that probably contributed to a hypercoagulable state. METHODS: We studied 82 patients with end-stage renal disease on maintenance HD therapy who underwent HD for 11 to 52 months (39.3 +/- 27.4 months). Forty-nine episodes of VAT occurred in 22 patients; a single episode occurred in 12 patients; and 2 or more episodes, in 10 patients. Blood coagulation studies, including assays of inhibitors and activated protein C (PC) resistance (APCR), were performed using standard techniques. RESULTS: Investigations showed the presence of lupus anticoagulant (LA) in 5.6%, anticardiolipin antibody immunoglobulin G (IgG) in 3.9% and IgM in 5.3%, APCR in 20.5%, and deficiencies in protein S (PS), PC, and antithrombin III (ATIII) in 32.1%, 24.4%, and 19.2%, respectively. When parameters were compared between patients with and without VAT episodes, LA, PC, PS, and APCR levels were significantly abnormal in those who experienced VAT. Sixteen subjects with hypercoagulable states on HD therapy underwent renal transplantation and were evaluated 9.3 +/- 4.2 months posttransplantation. Deficiencies in PC (P = 0.014), PS (P = 0.001), ATIII (P = 0.017), and APCR (P = 0.0001) were completely corrected in all subjects. CONCLUSION: Hypercoagulability is a risk factor for recurrent VAT in HD patients, and renal transplantation successfully corrects these abnormalities.

PMID: 14520631 [PubMed - indexed for MEDLINE]
 
 
 

Xanthomonas maltophilia infection in chronic peritoneal dialysis patients.
Al-Hilali N, Nampoory MR, Johny KV, Chugh TD.
Scand J Urol Nephrol. 2000 Feb;34(1):67-9.

Department of Medicine and Microbiology, Mubarak Al-Kabeer Hospital, Kuwait.

Xanthomonas maltophilia infection has only been occasionally reported in patients receiving chronic peritoneal dialysis. We describe four cases of Xanthomonas maltophilia infection associated with chronic peritoneal dialysis. Two patients presented with peritonitis and two with exit site infection. All patients were diabetics, who immediately prior to the study had not received antibiotic therapy. Failure to respond to multiple antibiotic therapy resulted in catheter removal in both patients with peritonitis. In those patients with only exit site infections, dialysis could be continued following antibiotic therapy and catheter replacement in one. Catheter loss in our patients was directly attributed to peritonitis with Xanthomonas maltophilia infection.

PMID: 10757274 [PubMed - indexed for MEDLINE]
 
 
The dialysed patient with both Castleman disease and Kaposi sarcoma.
Nampoory MR, Johny KV, Sarkar C, Al-Masry I, Al-Hilali N, Anim JT.

Nephrol Dial Transplant. (1998) 13 : 2373-2376.
Department of Medicine and Pathology, Mubarak Al-Kabeer Teaching Hospital and Faculty of Medicine, Kuwait University, Safat.
Publication Types:
  • Case Reports

PMID: 9761528 [PubMed - indexed for MEDLINE]


 

Profiled hemodialysis reduces intradialytic symptoms.
Al-Hilali N, Al-Humoud HM, Ninan VT, Nampoory MR, Ali JH, Johny KV.

Transplant Proc. 2004 Jul-Aug;36(6):1827-8.
Department of Medicine, Mubarak Al-kabeer Hospital, Kuwait.

A prospective study on the effect of profiled hemodialysis on intradialytic symptoms was undertaken among patients recruited between September 2002 and December 2002. Evaluated intradialytic symptoms included hypotension, muscle cramps, dizziness, headache, nausea, discomfort, thirst, and shortness of breath. Symptomatic patients were allocated to one mode of combined sodium and ultrafiltration profile during hemodialysis. The programs were readily available on Fresenius MC 4008 H&E hemodialysis machines. Evaluation was performed before profiling and at 2, 4, and 6 weeks into the profiled hemodialysis. On standard hemodialysis 40 (36.4%) patients were symptomatic. Hypotension was reported in 29 (72.5%) of patients receiving standard treatment. Dizziness, headache, and muscle cramps were reported in 22 (55%), 15 (37.5%), and 9 (22.5%) patients, respectively. These symptoms were significantly (P <.05) improved at 2, 4, and 6 weeks of profiling. Other symptoms, such as discomfort, nausea, vomiting, and thirst, were infrequently reported among patients without or with profiling. There was no significant difference between the applied profiles when compared with each other. In conclusion, sodium and ultrafiltration profiling are effective techniques to reduce acute adverse side effects of hemodialysis. They improve patient well-being and dialysis tolerance, minimize interventions during dialysis.

PMID: 15350488 [PubMed - in process]

 

Al-Hilali N1, Ninan VT1, Nampoory MRN1, Ali JH1, Johny KV1,2 Blood pressure control in hemodialysis patients; An Audit 1.Department of Medicine, Mubarak AI-Kabeer Hospital, Kuwait. 2.Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait

Objective: This audit was conducted to study the level of achievement of some criteria relevant to blood pressure control in hemodialysis patients and to evaluate if auditing process improves the quality of medical care given to these patients. Methods: Six criteria relevant to blood pressure control were selected for auditing in hemodialysis patients who were under the care of the dialysis unit in Mubarak Al-Kabeer Hospital Kuwait. The criteria included were dry weight [target standard of achievement 100%], Kt/V≥1.2 [target standard 100%], restricting salt and water intake [target standard 80%], patient education [target standard 75%], and predialysis blood pressure control <140/80 [target standard 80%]. Results: Records of 105 patients on maintenance hemodialysis were reviewed in February 2001 for the first data collection of the audit. Six months later 110 records were reviewed after implementing changes for the second data collection. In the first data collection of the audit the previously set standards were not being achieved. In the second data collection the audited criteria of predialysis blood pressure control, dry weight, and Kt/V≥1.2, and has significantly improved [P<0.0001]. The target standard however had not been achieved in all the audited criteria. Conclusion: There was a significant improvement in achievement of set standards observed in the second data collection with three of the criteria close to reaching the target standards set. Setting up audit cycles to evaluate achievement of required standard in relevant criteria contributes to better blood pressure control and leads to improvement in care of patient on dialysis.

 

Outcome and survival in different peritoneal dialysis modalities: Single center study

Nabieh Al-Hilali1, Vadakethu T.Ninan1, Hani Al-Humoud1, 2, Mangalathillam R.N. Nampoory1, Mini A Puliyclil2, Kaivilayil V. Johny1, 2

1Department of medicine, Mubarak Al-kabeer Hospital and 2Faculty of Medicine Kuwait University, Kuwait

Abstract

Background: Peritoneal dialysis modalities have well been accepted as a treatment option for patients with end stage kidney disease. Experience with peritoneal dialysis in Arab countries is limited. This study was undertaken to evaluate the outcome and survival of different peritoneal dialysis modalities in this population.

Methods: All patients managed in Mubarak Al-Kabeer Hospital Kuwait by peritoneal dialysis between August 1982 and December 2003 for 3 months or more were included in the study. Demographic features, outcome and survival of the patients were analyzed.

Results: Four hundred and fifteen patients with end stage renal failure were admitted into the peritoneal dialysis program. Their mean age was 52.06±16.43 years. Hospital based Intermittent peritoneal dialysis (IPD), Continuous ambulatory peritoneal dialysis (CAPD), Nightly intermittent peritoneal dialysis (NIPD) and Continuous Cycling Peritoneal Dialysis (CCPD) were preferred by 203(48.9%), 176 (42.4%), 30 (7.2%) and 6(1.4%) patients respectively. The mean duration of follow up was 12.7± 11.7 months. Fifty five (13.3%) patients were continuing on peritoneal dialysis, 55(13.3%) had shifted to haemodialysis, 73(17.6%) underwent renal transplantation, 114(27.5%) expired, 34(8.2%) return to their native countries, 79(19%) transferred to other centers and follow up was lost for 5(1.45%) patients. Patient survival at 2 years was 52.3%, 69.2% and 74.8% in IPD, CAPD, and NIPD respectively. Technique survival at 2 years was 60.6%, 75.4% and 100% in IPD, CAPD, and NIPD respectively.   

Conclusions: Peritoneal dialysis modalities provide a feasible modality of renal replacement therapy. The overall outcome and patient and technique survival in home peritoneal dialysis modalities were better than hospital based peritoneal dialysis.